Eradication of infectious diseases

Gloucester smallpox epidemic, 1896; Henry Wicklin, aged 6 Wellcome V0031456

Eradication of infectious diseases refers to the complete and permanent worldwide reduction to zero new cases of an infectious disease through deliberate efforts, leaving no need for further vaccination or other public health interventions. The concept is distinct from disease elimination, which reduces the number of cases in a specific geographic area. Eradication is the ultimate goal in the control of infectious diseases and has been achieved only with smallpox, declared eradicated in 1980.

Definition and Criteria

Eradication means that no further virus, bacteria, or other pathogens responsible for the disease exist in the wild, and no further cases can occur without reintroduction of the pathogen. For a disease to be considered for eradication, several criteria must be met:

• The disease must be identifiable with an accurate diagnostic tool.
• Effective intervention must be available to interrupt transmission of the pathogen.
• Humans must be the only reservoir for the pathogen.
• The disease must have a known distribution and must be a significant public health problem.

Successful Eradication Efforts

Smallpox is the only human disease to have been eradicated so far. The global effort led by the World Health Organization (WHO) culminated in the last natural case in 1977, with the eradication declared in 1980. This success was achieved through widespread vaccination campaigns and surveillance.

Ongoing Eradication Programs

Several other diseases are targets of global eradication programs, including:

• Poliomyelitis (polio), with efforts led by the Global Polio Eradication Initiative.
• Guinea worm disease (dracunculiasis), targeted by the Carter Center and partners.
• Measles and rubella, with various regional initiatives aiming for elimination, which is considered a step towards global eradication.

Challenges in Eradication

Eradicating infectious diseases faces numerous challenges:

• Biological complexity of pathogens can make vaccine development difficult.
• Vaccine hesitancy and refusal can lead to pockets of unvaccinated populations.
• Political and economic instability can disrupt public health efforts.
• Diseases with animal reservoirs require cross-species management strategies.

Ethical and Economic Considerations

Eradication efforts must balance ethical considerations, such as the rights of individuals versus the public health benefit, with economic considerations. The cost of eradication programs can be high, but the long-term savings from not having to treat or manage the disease can outweigh initial investments.

Future Prospects

Advances in genetics, vaccinology, and global health governance offer new tools and opportunities for disease eradication. However, global cooperation and sustained funding are essential to overcome the remaining challenges.